Name: Spruce Biosciences, Inc. (SPRB) Financial Statements
Creator: FinSpry

Spruce Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Spruce Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	4.91	10.09	0.00	0.00	0.00
Cost of Revenue	0.00	49.43	35.20	0.00	0.00
Gross Profit	4.91	10.10	-35.20	0.00	0.00
Operating Expenses
Research & Development	46.42	49.43	35.20	30.70	23.85
Selling, General & Administrative	14.64	12.65	12.09	11.37	5.56
Operating Expenses	61.06	62.08	47.28	42.07	29.42
Operating Income	-56.15	-51.99	-47.28	-42.07	-29.42
Other Income/Expense
Interest Income	3.42	4.56	1.52	0.12	0.20
Interest Expense	0.31	0.48	0.42	0.35	-0.32
Other Income/Expense	3.12	0.00	-0.75	0.12	0.00
Income
Income Before Tax	-53.04	-47.92	-46.18	-42.29	-29.54
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-53.04	-47.92	-46.18	-42.29	-29.54
Net Income - Continuous Operations	-53.04	-47.92	-46.18	-42.29	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-52.68	-47.37	-45.69	-41.88	-29.38
EBIT	-52.73	-47.44	-45.76	-41.95	-29.42
Depreciation & Amortization	0.05	0.07	0.07	0.07	0.04
Earnings Per Share
Basic EPS	-97.00	-93.00	-147.00	-136.00	-370.00
Diluted EPS	-97.00	-93.00	-147.00	-136.00	-370.00
Basic Shares Outstanding	0.54	0.51	0.31	0.31	0.08
Diluted Shares Outstanding	0.54	0.51	0.31	0.31	0.08